West Nile virus (WNV) is a mosquito-borne flavivirus responsible for epidemics of febrile illness, meningitis, encephalitis and flaccid paralysis. WNV gains entry into host cells through endocytosis. The acid pH inside endosomes triggers rapid conformational rearrangements of the flavivirus envelope (E) glycoprotein that result in fusion of the endosomal membrane with the virion envelope. Conformational rearrangements of the E glycoprotein can be induced by acid exposure in solution in the absence of target membranes, thus causing a loss of infectivity. Following a genetic approach to study this process, a WNV mutant with increased resistance to acid-induced inactivation was isolated and its complete genome was sequenced. A single amino acid substitution, T70I, in the E glycoprotein was found to be responsible for the increased acid resistance, which was linked to an increase in the sensitivity of infection to the chemical rise of endosomal pH, suggesting that the mutant required a more acid pH inside the endosomes for fusion. No alterations in viral infection kinetics, plaque size or induced mortality rates in mice of the mutant were noted. However, by means of virus competition assays, a reduction in viral fitness under standard culture conditions was observed for the mutant. These results provide new evidence of the adaptive flexibility to environmental factors -pH variation in this case -of WNV populations. Implications of the T70I replacement on the E glycoprotein structure-function relationship are discussed.
INTRODUCTIONWest Nile virus (WNV) is a mosquito-borne flavivirus that cycles between several species of mosquitoes and birds, and also infects a broad range of vertebrates, including humans (Hayes et al., 2005a). After its first description in Uganda in 1937(Smithburn et al., 1940, WNV has been associated with sporadic outbreaks of meningoencephalitis in Africa and the Middle East until 1999, when the virus emerged in the USA causing thousands of infections among humans, horses and birds (Lanciotti et al., 1999). Although WNV infections in humans are mainly subclinical, clinically apparent infections range from a febrile illness (West Nile fever) to a neuroinvasive disease associated with high mortality (DeBiasi & Tyler, 2006; Hayes et al., 2005b). Despite great effort having been invested in understanding the molecular aspects of WNV infection, currently there is no vaccine or specific therapy approved for use in humans (Diamond, 2009).The WNV genome comprises a single-stranded, positivesense RNA molecule (approx. 11 000 nt) that encodes three structural proteins -the capsid (C), pre-membrane/ membrane (prM/M) and envelope (E) proteins -and seven non-structural proteins, generated by cleavage of a single polyprotein (Brinton, 2002). The genomic RNA is enclosed within a nucleocapsid composed of multiple copies of the C protein, which constitutes the core of the virion and is enveloped by a lipid bilayer derived from the host cell. Cryoelectron microscopy studies have revealed that mature virions are ...